Screening for undiagnosed NAFLD and NASH (SUNN study) (H-43993)
Description
Content
This is a pilot study to help determine the incidence of undiagnosed NAFLD or NASH, to provide additional resources to research participants regarding their liver fibrosis, and to determine the effectiveness of using the CAP-FibroScan as a screening modality. Research participants will self-identify; there is no control group nor group assignment.
Contact
Phone 1: 713–798–1037
IRB: H-43993
Status:
Active
Created:
